Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yawen Hou

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Biopharmaceutical Statistics|November 22, 2017
Sample size for a noninferiority clinical trial with time-to-event data in the presence of competing risksDong Han, Zheng Chen, Yawen Hou
Journal of Evaluation in Clinical Practice|August 10, 2022
Investigations of methods for multiple time-to-event endpoints: A chronic myeloid leukemia data analysisHongji Wu, Yawen Hou, Zheng Chen
BMC Medical Research Methodology|July 27, 2020
The use of restricted mean time lost under competing risks dataJingjing Lyu, Yawen Hou, Zheng Chen
International Journal of Epidemiology|September 22, 2023
Communicating and understanding statistical measures when quantifying the between-group difference in competing risksHongji Wu, Chengfeng Zhang, Yawen Hou, et al.
Biometrics|June 20, 2023
Analysis of dynamic restricted mean survival time based on pseudo-observationsZijing Yang, Chengfeng Zhang, Yawen Hou, et al.
BMJ Open|July 22, 2020
Moving beyond the Cox proportional hazards model in survival data analysis: a cervical cancer studyLixian Li, Zijing Yang, Yawen Hou, et al.
Statistical Methods in Medical Research|August 6, 2024
Sample size calculation for mixture cure model with restricted mean survival time as a primary endpointZhaojin Li, Xiang Geng, Yawen Hou, et al.
Statistical Methods in Medical Research|January 20, 2025
Group sequential design using restricted mean survival time as the primary endpoint in clinical trialsZhaojin Li, Xiang Geng, Yawen Hou, et al.
Talanta|June 4, 2026
Rapid and specific detection of hydrazine in environmental samples with a malononitrile functionalized DTTO probe and smartphone based analysisRuofeng Xu, Yujiao Hou, Yawen Hou, et al.
Pharmaceutical Statistics|June 2, 2020
Comparison of two treatments in the presence of competing risksJingjing Lyu, Jinbao Chen, Yawen Hou, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Biopharmaceutical Statistics|November 22, 2017
Sample size for a noninferiority clinical trial with time-to-event data in the presence of competing risksDong Han, Zheng Chen, Yawen Hou
Journal of Evaluation in Clinical Practice|August 10, 2022
Investigations of methods for multiple time-to-event endpoints: A chronic myeloid leukemia data analysisHongji Wu, Yawen Hou, Zheng Chen
BMC Medical Research Methodology|July 27, 2020
The use of restricted mean time lost under competing risks dataJingjing Lyu, Yawen Hou, Zheng Chen
International Journal of Epidemiology|September 22, 2023
Communicating and understanding statistical measures when quantifying the between-group difference in competing risksHongji Wu, Chengfeng Zhang, Yawen Hou, et al.
Biometrics|June 20, 2023
Analysis of dynamic restricted mean survival time based on pseudo-observationsZijing Yang, Chengfeng Zhang, Yawen Hou, et al.
BMJ Open|July 22, 2020
Moving beyond the Cox proportional hazards model in survival data analysis: a cervical cancer studyLixian Li, Zijing Yang, Yawen Hou, et al.
Statistical Methods in Medical Research|August 6, 2024
Sample size calculation for mixture cure model with restricted mean survival time as a primary endpointZhaojin Li, Xiang Geng, Yawen Hou, et al.
Statistical Methods in Medical Research|January 20, 2025
Group sequential design using restricted mean survival time as the primary endpoint in clinical trialsZhaojin Li, Xiang Geng, Yawen Hou, et al.
Talanta|June 4, 2026
Rapid and specific detection of hydrazine in environmental samples with a malononitrile functionalized DTTO probe and smartphone based analysisRuofeng Xu, Yujiao Hou, Yawen Hou, et al.
Pharmaceutical Statistics|June 2, 2020
Comparison of two treatments in the presence of competing risksJingjing Lyu, Jinbao Chen, Yawen Hou, et al.
Pageof 4